08 Aug MHRA approves licence 8th August 2018
Biotherapy Services Limited
MHRA approves licence MIA/(IMP) for the point-of-care manufacture of RAPIDTM Biodynamic Haematogel treatment.
Biotherapy Services Ltd. announces the granting of the MIA/(IMP) and “Specials” licences for our proprietary RAPIDTM Biodynamic Haematogel wound care treatment for complex and chronic wounds, was issued on 8thAugust 2018
For further information, please contact:
Biotherapy Services Ltd
Janet Hadfield, Chief Executive Officer
Info@biotherapyservices.comTel: ++44 (0) 207 788 7828